Axonics says that its device significantly reduces the user's need to recharge as it marks its second clearance in only a ...
Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics R20® rechargeable sacral neuromodulation ...
The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna ...
Axonics announced today that it received regulatory approval in Australia for its R20 rechargeable sacral neuromodulation ...
Despite being an essential part of overall well-being, many women don't realize how much their urinary and pelvic health can ...
If you have to get out of bed to run to the bathroom at night, you know how badly it can mess up your sleep. Thankfully, ...
Sometimes asking questions about your health and aging can be uncomfortable, or even embarrassing, but it doesn’t have to be ...